The effect of DC+CIK combined therapy on rat liver cancer model and its modulatory effect on immune functions.
CONCLUSIONS: DC+CIK combined therapy can protect the host against tumors invasion via modulating body immune or liver function, regulating apoptosis/anti-apoptosis balance, which shows better efficacy than CIK alone, and can work as a novel biological therapeutic strategy for liver cancer.
PMID: 29461610 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Bone Graft | Cancer | Cancer & Oncology | Drugs & Pharmacology | Liver | Psychology | Study | Urology & Nephrology